Ajanta Pharma Ltd vs Concord Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Ajanta Pharma Ltd is ₹ 3129 as of 12 Jun 15:30 . The P/E Ratio of Ajanta Pharma Ltd changed from 21.8 on March 2022 to 23.9 on March 2021 . This represents a CAGR of 1.86% over 5 yearsThe P/E Ratio of Concord Drugs Ltd changed from 15.9 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years The Market Cap of Ajanta Pharma Ltd changed from ₹ 15452 crore on March 2022 to ₹ 15517 crore on March 2021 . This represents a CAGR of 0.08% over 5 yearsThe Market Cap of Concord Drugs Ltd changed from ₹ 25.36 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years The revenue of Ajanta Pharma Ltd for the Mar '26 is ₹ 1483 crore as compare to the Dec '25 revenue of ₹ 1399 crore. This represent the growth of 5.95% The revenue of Concord Drugs Ltd for the Mar '26 is ₹ 37.9 crore as compare to the Dec '25 revenue of ₹ 16.99 crore. This represent the growth of 123.07% The ebitda of Ajanta Pharma Ltd for the Mar '26 is ₹ 394.84 crore as compare to the Dec '25 ebitda of ₹ 407.21 crore. This represent the decline of -3.04% The ebitda of Concord Drugs Ltd for the Mar '26 is ₹ 1.5 crore as compare to the Dec '25 ebitda of ₹ 0.94 crore. This represent the growth of 59.57% The net profit of Ajanta Pharma Ltd changed from ₹ 245.77 crore to ₹ 266.7 crore over 8 quarters. This represents a CAGR of 4.17% The net profit of Concord Drugs Ltd changed from ₹ 0.03 crore to ₹ 0.53 crore over 8 quarters. This represents a CAGR of 320.32% The Dividend Payout of Ajanta Pharma Ltd changed from 12.23 % on March 2021 to 38.28 % on March 2025 . This represents a CAGR of 25.63% over 5 yearsThe Dividend Payout of Concord Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Ajanta Pharma Ltd

Ajanta Pharma Limited is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
The Company is involved in development, manufacturing and marketing of quality finished dosages in domestic and international markets.
It produces a comprehensive range of specialty products targeting different therapeutic segments.
It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

FAQs for the comparison of Ajanta Pharma Ltd and Concord Drugs Ltd

Which company has a larger market capitalization, Ajanta Pharma Ltd or Concord Drugs Ltd?

Market cap of Ajanta Pharma Ltd is 39,096 Cr while Market cap of Concord Drugs Ltd is 101 Cr

What are the key factors driving the stock performance of Ajanta Pharma Ltd and Concord Drugs Ltd?

The stock performance of Ajanta Pharma Ltd and Concord Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ajanta Pharma Ltd and Concord Drugs Ltd?

As of June 15, 2026, the Ajanta Pharma Ltd stock price is INR ₹3129.35. On the other hand, Concord Drugs Ltd stock price is INR ₹77.31.

How do dividend payouts of Ajanta Pharma Ltd and Concord Drugs Ltd compare?

To compare the dividend payouts of Ajanta Pharma Ltd and Concord Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.